SAN FRANCISCO (360Dx) - The 36th annual JP Morgan Healthcare Conference kicked off here on Monday with some of the biggest players in the molecular diagnostics industry presenting. Below are brief reports on the presentations and breakout sessions covered by our team at the conference.

Genomic Health

Following an expected profitable 2017, Genomic Health CEO Kim Popovits said that the company expects to record another profit in 2018 fueled by anticipated double-digit growth in 2018 revenues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.